In vitro fertilization treatment in patients with polycystic ovaries
暂无分享,去创建一个
[1] S. Lipitz,et al. Polycystic ovarian syndrome: pregnancy outcome following in vitro fertilization-embryo transfer. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[2] R. Norman,et al. Endocrinology: Immunoactive interleukin-1β and tumour necrosis factor-α in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries , 1995 .
[3] G. Lefèbvre,et al. How many embryos should be transferred in in vitro fertilization? A prospective randomized study. , 1994, Fertility and sterility.
[4] A. Lanzone,et al. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. , 1994, Fertility and sterility.
[5] Z. Ben-Rafael,et al. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. , 1993, Fertility and sterility.
[6] S. L. Tan,et al. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. , 1993, Human reproduction.
[7] D. Magoffin,et al. Granulosa cells of polycystic ovaries: are they normal or abnormal? , 1992, Human reproduction.
[8] J. Dor,et al. The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study. , 1992, Fertility and sterility.
[9] E. Rudak,et al. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.
[10] A. Lucky,et al. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome , 1990 .
[11] J. Eden,et al. FOLLICULAR FLUID CONCENTRATIONS OF INSULIN‐LIKE GROWTH FACTOR 1, EPIDERMAL GROWTH FACTOR, TRANSFORMING GROWTH FACTOR‐ALPHA AND SEX‐STEROIDS IN VOLUME MATCHED NORMAL AND POLYCYSTIC HUMAN FOLLICLES , 1990, Clinical endocrinology.
[12] J. Adams,et al. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. , 1988, BMJ.
[13] K. Fredga,et al. Ploidy in human cleavage stage embryos after fertilization in vitro. , 1987, Human reproduction.
[14] R. Edwards,et al. EFFECT OF HIGH TONIC LEVELS OF LUTEINISING HORMONE ON OUTCOME OF IN-VITRO FERTILISATION , 1986, The Lancet.
[15] E. Porcu,et al. Comparison Between Human Urinary Follicle‐Stimulating Hormone and Human Menopausal Gonadotropin Treatment in Polycystic Ovary , 1984, Obstetrics and gynecology.
[16] J. Halme,et al. Factors Affecting the Pregnancy Rate in Clomiphene Citrate Induction of Ovulation , 1983, Obstetrics and gynecology.
[17] D. Mishell,et al. Clinical and laboratory predictors of clomiphene response. , 1982, Fertility and sterility.
[18] Hughes Pe. Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis” , 1982 .
[19] C. Gemzell,et al. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. , 1980, Fertility and sterility.
[20] M. J. Whitelaw,et al. The significance of the high ovulation rate versus the low pregnancy rate with Clomid. A review of 203 private anovulatory patients. , 1970, American journal of obstetrics and gynecology.
[21] R. Norman,et al. Immunoactive interleukin-1 beta and tumour necrosis factor-alpha in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries. , 1995, Human reproduction.
[22] A. Lucky,et al. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. , 1990, Fertility and sterility.
[23] P. Hughesdon. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". , 1982, Obstetrical & gynecological survey.